Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers
Background and objective This review aims to provide an overview of novel diagnostic and
therapeutic radiopharmaceuticals tested recently or used currently in genitourinary cancers …
therapeutic radiopharmaceuticals tested recently or used currently in genitourinary cancers …
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review
L Filippi, L Urso, O Schillaci, L Evangelista - Diagnostics, 2023 - mdpi.com
The aim of this systematic review is to provide a comprehensive overview of the role of fluoro-
5α-dihydrotestosterone ([18F]-FDHT) for the in vivo imaging of androgen receptors (AR) …
5α-dihydrotestosterone ([18F]-FDHT) for the in vivo imaging of androgen receptors (AR) …
Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga] Ga-PSMA-11 and [18F] PSMA-1007
Purpose Prostate-specific membrane-antigen positron emission tomography (PSMA PET) is
a promising candidate for non-invasive characterization of prostate cancer (PCa). This study …
a promising candidate for non-invasive characterization of prostate cancer (PCa). This study …
[18F]FDHT tumour imaging for predicting response to treatment based on androgen receptor
AM Muhammad, W Dun, Z Ashhar… - … of Radioanalytical and …, 2024 - Springer
The preliminary role of [18F] fluoro-5α-dihydrotestosterone ([18F] FDHT) in identifying
receptor status and managing cancer patients is promising. In this work, we compiled …
receptor status and managing cancer patients is promising. In this work, we compiled …
Les radiotraceurs autres que le PSMA-ligand pour l'imagerie TEP du cancer de prostate
N Withofs, R Hustinx, C Morgat - Médecine Nucléaire, 2023 - Elsevier
Résumé La TEP/TDM ciblant l'antigène membranaire spécifique de la prostate (PSMA) est
la technique d'imagerie de choix du cancer de prostate. Elle a cependant des limites …
la technique d'imagerie de choix du cancer de prostate. Elle a cependant des limites …